Central Laboratory, First Affiliated Hospital of Bengbu Medical College, Anhui 233004, People's Republic of China.
Neurotherapeutics. 2012 Apr;9(2):422-45. doi: 10.1007/s13311-011-0090-9.
Neural stem cell (NSC) transplantation is a major focus of current research for treatment of spinal cord injury (SCI). However, it is very important to promote the survival and differentiation of NSCs into myelinating oligodendrocytes (OLs). In this study, myelin basic protein-activated T (MBP-T) cells were passively immunized to improve the SCI microenvironment. Olig2-overexpressing NSCs were infected with a lentivirus carrying the enhanced green fluorescent protein (GFP) reporter gene to generate Olig2-GFP-NSCs that were transplanted into the injured site to differentiate into OLs. Transferred MBP-T cells infiltrated the injured spinal cord, produced neurotrophic factors, and induced the differentiation of resident microglia and/or infiltrating blood monocytes into an "alternatively activated" anti-inflammatory macrophage phenotype by producing interleukin-13. As a result, the survival of transplanted NSCs increased fivefold in MBP-T cell-transferred rats compared with that of the vehicle-treated control. In addition, the differentiation of MBP-positive OLs increased 12-fold in Olig2-GFP-NSC-transplanted rats compared with that of GFP-NSC-transplanted controls. In the MBP-T cell and Olig2-GFP-NSC combined group, the number of OL-remyelinated axons significantly increased compared with those of all other groups. However, a significant decrease in spinal cord lesion volume and an increase in spared myelin and behavioral recovery were observed in Olig2-NSC- and NSC-transplanted MBP-T cell groups. Collectively, these results suggest that MBP-T cell adoptive immunotherapy combined with NSC transplantation has a synergistic effect on histological and behavioral improvement after traumatic SCI. Although Olig2 overexpression enhances OL differentiation and myelination, the effect on functional recovery may be surpassed by MBP-T cells.
神经干细胞(NSC)移植是治疗脊髓损伤(SCI)的当前研究重点。然而,促进 NSCs 存活并分化为髓鞘形成少突胶质细胞(OLs)非常重要。在这项研究中,通过被动免疫髓鞘碱性蛋白激活 T(MBP-T)细胞来改善 SCI 微环境。用携带增强型绿色荧光蛋白(GFP)报告基因的慢病毒感染过表达 Olig2 的 NSCs,生成 Olig2-GFP-NSCs,将其移植到损伤部位分化为 OLs。转移的 MBP-T 细胞浸润损伤的脊髓,产生神经营养因子,并通过产生白细胞介素 13 诱导驻留小胶质细胞和/或浸润的血单核细胞分化为具有“替代激活”抗炎表型的巨噬细胞。结果,与载体处理对照组相比,MBP-T 细胞转移大鼠中转基因 NSCs 的存活率增加了五倍。此外,与 GFP-NSC 移植对照组相比,Olig2-GFP-NSC 移植大鼠中 MBP 阳性 OL 分化增加了 12 倍。在 MBP-T 细胞和 Olig2-GFP-NSC 联合组中,与所有其他组相比,OL 再髓鞘化轴突的数量显著增加。然而,在 Olig2-NSC 和 NSC 移植的 MBP-T 细胞组中,观察到脊髓损伤体积显著减小,髓鞘保留增加,行为恢复改善。总之,这些结果表明,MBP-T 细胞过继免疫治疗联合 NSC 移植对创伤性 SCI 的组织学和行为改善具有协同作用。虽然 Olig2 过表达增强 OL 分化和髓鞘形成,但对功能恢复的影响可能被 MBP-T 细胞超越。